Milnacipran in the Treatment of Widespread, Non-Joint Pain in Rheumatoid Arthritis

Trial Profile

Milnacipran in the Treatment of Widespread, Non-Joint Pain in Rheumatoid Arthritis

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Dec 2015

At a glance

  • Drugs Milnacipran (Primary)
  • Indications Musculoskeletal pain; Rheumatoid arthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Dec 2015 Primary endpoint (change in average pain intensity, assessed by the brief pain inventory short form) has not been met according to the results published in The Journal of Rheumatology.
    • 01 Dec 2015 Results published in The Journal of Rheumatology
    • 25 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top